ArticlePDF Available

Pharmacognosy Magazftie The effect of the aqueous stem bark extract of Kokoona zeylamca Thw. on the blood glucose level of mice

Authors:

Abstract

This study examined the blood glucose lowering potential of the aqueous stem bark extract (ABE) of Sri Lankan endemic plant-Kokoona zeylanica (Family: Celestraceae). This was tested in normoglycaemic mice using three oral doses (1800, 2500 and 3000 mg/kg of body weight). The results show a moderate but dose dependant acute hypoglycaemic activity with a fairly rapid onset (4 h). However, It did not have a hypoglycaemic effect in non fasted mice or in fasted mice (treated consecutively for 30 days). ABE did not improve the glucose tolerance test indicating the Lack of antihyperglycaemic activity. However, ABE improved the sucrose tolerance test indicating the a-glucosidase inhibitory activity, which appears to be the main mechanism of hypoglycaemic activity. ABE was well tolerated {in terms of overt clinical signs of toxicity, hepatotoxicity and renotoxicity), and it did not provoke a change in the lipid profile. It is concluded that the ABE of K. zeylanica has a safe, moderate and acute hypoglycaemic activity
Pharmacognosy
Magazftie
ISSN:
0973-1296
PHCOG MAG.
An
official
Pubiication of Phcog.Net;
PHCOG
MAG.:
Research
Article
The
effect
of the
aqueous
stem
bark
extract
of
Kokoona
zeylamca
Thw. on the
blood
glucose
level
of
mice
P.D.
Dayananda,
W.B.
Yapa
and W.D.
Ratnasooriya
Department
of
Zoology,
University
of
Colombo.
Colombo
03, Sri
Lanka
Address
correspondence:
wdr@zoology.cmb.ac.lk
ABSTRACT
This study examined the blood glucose lowering potential of the aqueous stem bark extract (ABE) of Sri Lankan
endemic plant -
Kokoona
zeylanica (Family: Celestraceae). This was tested in normoglycaemic mice using three
oral
doses
(1800,
2500
and
3000
mg/kg
of body weight). The results show a moderate but dose dependant acute
hypoglycaemic activity with a fairly rapid onset (4 h). However, It did not have a hypoglycaemic effect in non
fasted
mice or in fasted mice (treated consecutively for 30 days). ABE did not improve the glucose tolerance test
indicating
the Lack of antihyperglycaemic activity. However, ABE improved the sucrose tolerance test indicating
the
a-glucosidase inhibitory activity, which appears to be the main mechanism of hypoglycaemic activity. ABE was
well
tolerated {in terms of overt
clinical
signs
of toxicity, hepatotoxicity and renotoxicity), and it did not provoke
a change in the
lipid
profile. It is concluded that the ABE of K. zeylanica has a safe, moderate and acute
hypoglycaemic activity
KEY
WORDS:
Kokoona
zeylanica, Hypoglycaemia," Diabetes, Toxicity
INTRODUCTION
Kokoona
zeylanica Thw. (Family: Celestraceae) is a
large tree (20 - 35 m high) branched towards the top
with
a rough outer bark which is corky and grey in
colour
and an inner bark which is bright yellow or dark
orange in colour. Leaves are obovate, cuneate at base,
rounded or letuse at apex with serrated margins
entirely
or faintly. Flowers are in axillary panicles,
bisexual and duU yellowish brown in colour, (1).
Kokoona
species occur in the Annamallay hills in India
and in Sri Lanka.
Kokoona
zeylanica is endemic to Sri
Lanka, which is rather rare in the country and found in
forests (Pelawatte, Pasdun Korale, Ratnapura,
Ambagamuwa, Udugama and Hiniduma) in moist
regions between 1000 -
4000
feet altitude (2, 3).
According to phytochemical studies, the water extract
has revealed the presence of alkaloids, saponins,
terpenes and tannins in the inner stem bark of K.
zeylanica (4). Twelve D:A-friedo-oleanane triterpenes
have been isolated from the hot benzene extract of
the
inner stem bark of K. zeylanica (5). Zeylasterone,
pristimerin
(6), minor triterpene and celastranhydride
(7) are also recorded from the outer stem bark of K.
zeylanica from the light petroleum extract.
In the traditional medicine, the inner bark is used as a
treatment
for snakebites, swollen Joints, eye diseases,
framboesia pimples and skin diseases. The inner bark
may also be used to lighten the colour of the skin and
for
removing marks from the face. It is often used as a
snuff for severe headaches and the oil from the seed is
used as a leech repellent (2). K. zeylanica is also
claimed
to be useful as a treatment for diabetes
mellitus
(2, 8, 9). Several of the multiplant decoctions
for
diabetes mellitus also contain the inner stem bark
of K. zeylanica as one of the components (8). However,
so far its effect on blood glucose
level
has not been
scientifically
investigated. The aim of this study was to
examine the hypoglycemic potential, and the toxic
effects
of the aqueous stem bark extract of K.
zeylanica.
MATERIALS
AND
METHODS
Plant
collection authentication
The stem bark of K. zeylanica was purchased from D.
Peris a
Sons
Ltd.
Drug
Merchants, Gabo's Lane,
Pettah,
Colornbo and was identified and authenticated
by Dr. M. Chandrasena of the Institute of
Indigenous
Medicine,
University of Colombo. A voucher specimen
of the leaves and bark
(WDR/kokun)
was deposited at
the
museum of the Department of Zoology.
Preparation
of the ABE of K.zeylanica
The outer gray bark of the K. zeylanica was removed
and the pieces of inner bark were dried in the shade
for
two
days
and powdered using a mechanical grinder
(Sumeet Master No: 864, Sumeet machines Ltd, Nasik,
India). The powder (750 g) was mixed with tap water
and then refluxed with 4 I of tap water for two
days
in
a round bottom flask
fitted
to a Leibig's condenser.
308
... 2 Many of the plant based decoctions used in the treatment of diabetes mellitus contains the inner stem bark of K. Zeylanica. 4 Phytochemical studies have led to the isolation of many triterpenoids from the inner stem bark and zeylasterone, demethylzeylasterone, zeylasteral, demethylzeylasteral (6-oxo phenolic triterpenoids), pristimerin, celastranhydirde and minor terpenoids from the outer stem bark of K. zeylaninca. 4,5 During the latter years this plant has been studied scientifically in order validate the claims made in use of it in folk medicine to alleviate many ailments. ...
... 4 Phytochemical studies have led to the isolation of many triterpenoids from the inner stem bark and zeylasterone, demethylzeylasterone, zeylasteral, demethylzeylasteral (6-oxo phenolic triterpenoids), pristimerin, celastranhydirde and minor terpenoids from the outer stem bark of K. zeylaninca. 4,5 During the latter years this plant has been studied scientifically in order validate the claims made in use of it in folk medicine to alleviate many ailments. ...
... 12 The aqueous bark extract of k. zeylanica has been also show to contain safe, moderate and acute hypoglyceamic activity. 4 However, to our knowledge, there are no scientific studies reported on the antinociceptive activity of the inner stem bark of K.zeylanica to substantiate its ethno medicinal use. Hence, in the present study, the aqueous extract of inner stem bark (AISBE) was examined for its antinociceptive activity. ...
Article
Full-text available
Kokoona zeylanica Thw is an endemic plant in Sri Lanka and has been used for many centuries past in the traditional system of medicine for alleviation of many ailments including headaches. The aim of this study was to scientifically investigate the antinociceptive potential of bark of Sri Lankan endemic plant, Kokoona zeylanica Thw. Different concentrations (750, 1500, 2500 mg kg-1) of aqueous inner stem bark extract (AISBE) was prepared. AISBE was orally administered to rats and antinociceptive activity was determined using three models of nociception (tail flick, hot plate and formaline tests). The results showed that AISBE has significant (P < 0.05) and dose-dependent antinociceptive activity (when evaluated in hot plate and formaline tests but not in the tail flick test). The antinociceptive activity had a rapid onset (1 h) and fairly long duration of action (5 h).The AISBE induced antinociception was not blocked by naloxone or atropine but was inhibited by metochlopramide indicating dopaminergic mode of action. Further, AISBE had mild sedative and moderate antioxidant activities which may play an auxiliary role in inducing antinociceptive activity. AISBE was not toxic (in terms of mortality in brine shrimp assay) and was well tolerated (in terms of overt signs, renal, hepatic and haematological toxicities). It is concluded that AISBE of K. zeylanica has safe and moderate oral antinociceptive activity supporting its use as painkiller in traditional medicine.
... It was observed that AEF exerted its hypoglycemic effects through none dose-dependant manner with the mid dose producing pronounced hypoglycaemic effect. Further, the extract did produce a delayed hypoglycemic effect after 4 h and such delayed activity had been reported previously in plants such as Kokoona zeylanica L. [24], Strychnos henningsii L. [25] and Phylanthus debilis L. [26]. High dose of the extract exhibiting less hypoglycemic activity than the mid dose may be due to receptor down regulation activity of the drug thus decreasing the number of receptors for a drug or presence of other phytochemical substances [27]. ...
Article
Full-text available
Boiled aqueous extract of flowers (AEF) from Nyctanthes arbor-tristis L. are used in Sri Lankan traditional Ayruvedic Medicine to manage diabetes mellitus. AEF has widely been used as a folk medicine for the treatment of various ailments due to its therapeutic activity. However, little is known concerning therapeutic activity of the extract as well as its underline mechanisms and safety. Diabetes is known to increase low-density cholesterol and decrease high-density cholesterol thus triggering coronary diseases. Hence, the primary objective of the present study is to investigate the hypoglycemic and hypolipidemic activities of the AEF. AEF was prepared and male mice (n = 9 group) were gavaged either with 250, 500 and 750 mg/kg of AEF or distilled water (DW). Subsequently, fasting and random blood glucose concentrations were determined. To investigate mechanisms of actions of AEF, animals were orally administered with 500 mg/kg or the vehicle (DW) and glucose tolerance was performed before and after glucose challenge. For further studies, in vitro alpha-amylase assay and glucose absorption from the gastrointestinal tract were performed using 500 mg/kg of the extract. Additionally, glycogen content in the liver and skeletal muscles, a complete lipid profile assay, and toxicological and biochemical parameters were conducted after a chronic study. Five hundred mg/kg and 750 mg/kg of AEF significantly (p < 0.01) reduced fasting blood glucose levels respectively by 49 and 39 % at 4 h post-treatment, while 500 mg/kg of AEF also decreased the random blood glucose level significantly (p <0.01) by 32 % at 4 h post-treatment. AEF significantly inhibited glucose absorption by 85 % from the intestine and increased diaphragm uptake of glucose by 64 %. The extract also exhibited inhibition (16.66 %) of alpha-amylase enzyme activity. It also decreased the level of total cholesterol (by 44.8 %), triglyceride (by 53 %) and increased (by 57 %) the high-density lipoprotein cholesterol. Treatment with AEF did not induce any overt signs of toxicity or hepatotoxicity. Results the present study indicated that AEF possess hypoglycemic and hypolipdemic properties. Therefore, AEF could be used as an alternative medicine in management of diabetes mellitus.
Article
Full-text available
Aporusa lindleyana is a medicinal plant, which is claimed to have a hypoglycaemic potential. This study was carried out to determine the hypoglycaemic effect, toxicity of long term usage and the phytochemistry of tender leaves of A. lindleyana. The hypoglycaemic effect of the methanolic leaf extract of A. lindleyana on the fasting and random blood glucose concentrations and the glucose tolerance were tested using three oral doses of the extract (100, 400, 800 mg/kg) in Sprague-Dawley rats. Sub-acute toxicity studies were performed after treating the rats for 28 consecutive days with the highest dose and were tested for different parameters. The results exhibit a dose dependent hypoglycaemic effect with the maximum blood glucose reduction observed at the 4th hour after the treatment. All three tested doses significantly reduced the fasting blood glucose concentration 4 hours after treatment. Only the intermediate and the highest doses showed a significant reduction in random blood glucose concentration in normoglycaemic non-fasted rats and a significant glucose tolerance, when tested on an oral glucose load. There was no significant difference in the physical and biochemical parameters in rats treated with the extract for 28 days compared to the control group. The extract contained alkaloids, saponins, flavonoids and leucoanthocyanins as revealed by phytochemical screening. It can be concluded that A. lindleyana leaves exhibit hypoglycaemic activity since they significantly (p < 0.05) reduce the blood glucose concentration in normoglycaemic rats and significantly (p < 0.05) enhances the glucose tolerance. The long term use of the leaf extract does not produce any toxic signs in rats.
Article
Prevalence of diabetes mellitus (DM) has reached epidemic proportions in Sri Lanka. We aim to systematically review the literature for studies on DM published by Sri Lankan authors and provide a comprehensive analysis of its prevalence, trends, and risk factors. Retrieval of diabetes-related research articles conducted in Sri Lanka was by a comprehensive systematic search of the literature in the following medical bibliographical databases: PubMed, Web of Science, SciVerse Scopus, CINAHL, and Cochrane Library. Studies published before January 6, 2012 was included. Search terms used were “Sri Lanka,” “Lanka,” “Ceylon,” “pre-diabetes,” “diabetes,” “type-2 diabetes,” “type-1 diabetes,” “diabetes mellitus,” “dysglycaemia,” and “glucose intolerance”. Studies not in English, conference proceedings, and abstracts were excluded. The number of studies included in the present systematic review is 96 (journal articles—82, dissertation—14). Our results based on the available latest national data (2005-2006) show that Sri Lanka is facing a significant burden of both diabetes (prevalence 10.3 %) and pre-diabetes (prevalence 11.5 %). Urban residency and familial inheritance appear to be important factors associated with diabetes in Sri Lanka. There were a number of ethno-medical studies done by Sri Lankan authors evaluating herbal products in diabetes treatment. DM is a major health problem in Sri Lanka, with an unprecedented current level of prevalence. Considering the gravity of the health issue and the economical burden, very little local research has been conducted to combat the epidemic. Future studies should be focused on the causes of this high prevalence, such as genetic characteristics, dietary habits, body composition, and level of physical activity.
Article
Full-text available
Many plants are found to be effective in the management of lifestyle diseases, there is an increased focus on herbal medicines in recent times. DIA7 is the Polyherbal formulation containing multiple ingredients of herbal origin, which are individually used in traditional system of medicine in the treatment of various metabolic disorders including Diabetic Mellitus. DIA7 consists of seven medicinal plants namely Salacia reticilata, Aegle marmelose, Azadirachta indica, Curcuma longa, Trigonella foenum graecum, Nigella sativa and Embilica officinalis. The above dried ingredients were powdered and formulated as DIA7 and administered orally to the animals by suspending in 0.5% Carboxy Methyl Cellulose solution. The effect of the Polyherbal Formulation DIA7 on fasting blood glucose level was evaluated by treatment with three dose levels i.e. 100, 200 and 400 mg/kg/day orally in both Alloxan induced diabetic rats for 28 days. From the study, DIA7 was found to be very effective in control of fasting blood glucose level in Alloxan induced diabetic rats, at a dose level of 400 mg/kg. The study indicates that the various active principles in DIA7 had produced a combined effect on fasting blood sugar level of the experimental rats.
Article
Zeylasterone, a new triterpene from Kokoona zeylanica, is shown to be 2,3-dihydroxy-6-oxo-24-nor-D:A-friedo-oleana-1,3,5(10),7-tetraen-23,29-dioic acid-29-methyl ester (20 α) (), the first member of a new series of phenolic 24-nor-D:A-friedo-oleanans.
Article
Three triterpenes obtained from the inner bark of Kokoona zeylanica have been identified as friedelin, D:A-friedo-olean-3, 21-dione and 21α-hydroxy- D:A-friedo-olean-3-one by spectroscopic properties and chemical interconversions. Their chemotaxonomic significance is emphasized.
Article
The structure of celastranhydride, a novel triterpene anhydride isolated fromKokoona zeylanica and present inCassine balae andReissantia indica, all of the family Celastraceae, has been deduced as 1 from its spectral data including 2-D heteronuclear1H13C shift correlated NMR spectra.
Article
Results from the United Kingdom Prospective Diabetes Study showed that intensive treatment of type 2 (non-insulin-dependent) diabetes mellitus, with sulphonylureas or insulin, significantly reduced microvascular complications but did not have a significant effect on macrovascular complications after 10 years. Insulin resistance plays a key role in type 2 diabetes mellitus and is linked to a cluster of cardiovascular risk factors. Optimal treatment for type 2 diabetes mellitus should aim to improve insulin resistance and the associated cardiovascular risk factors in addition to achieving glycaemic control. Treatment with sulphonylureas or exogenous insulin improves glycaemic control by increasing insulin supplies rather than reducing insulin resistance. Metformin and the recently introduced thiazolidinediones have beneficial effects on reducing insulin resistance as well as providing glycaemic control. There is evidence that, like metformin, thiazolidinediones also improve cardiovascular risk factors such as dyslipidaemia and fibrinolysis. Whether these differences will translate into clinical benefit remains to be seen. The thiazolidinediones rosiglitazone and pioglitazone have been available in the US since 1999 (with pioglitazone also being available in Japan). Both products are now available to physicians in Europe.
Article
In the work an effect of anthocyanins of red wine type Cabernet on the course and intensity of symptoms of the experimental diabetes in the rats has been examined. The estimation of the course of experimental diabetes was based on: determination of sugar concentration in urine and blood serum, determination of concentration of the unsaturated fatty acids peroxidation in urine and blood serum, also on the change of body mass during the experiment. The examination was carried out on 80, weighing 200-250 g, rats. They lived in the animal quarters with a stable temperature and humidity being fed with standard fodder (Murigan) with water supply in ever quantity. The rats were divided into the following four group: I--control group, II--group of animals receiving intraperitoneal streptozotocin in concentration 70 mg/kg m.c., III--group of animals receiving intragastric 10 mg/kg m.c. of natural anthocyanin dye of red wine type Cabernet, IV--group of animals receiving intraperitoneal 70 mg/kg m.c. of streptozotocin and simultaneously receiving intragastric 1 mg/kg m.c. of natural anthocyanin dye. An essential increase of glucose concentration in urine was found in the rats after streptozotocin injection. A simultaneous daily administration of anthocyanins obtained from red wine type Cabernet and streptozotocin substantially decreased sugar concentration in urine and blood serum. Those anthocyanins also inhibited loss of body mass caused by the former injection of streptozotocin. Simultaneously antocyan pigment was stated to considerably prevent generation of free oxygen radicals. The decrease of peroxidation of lipids, the measure of which was lowering of the concentration of the products of unsaturated fatty acids oxidation in urine and blood serum was also observed.
Article
A water-soluble Touchi-extract (TE) exerts a potent inhibitory activity against rat intestinal alpha-glucosidase in foodstuffs, and elicited anti-glycemic effects in rats and humans with single-bolus oral administration. In the present study, genetically modified diabetic model KKAy mice were used to examine the long-term effects of TE. Eight-week-old male KKAy mice were fed with CE-2 chow containing 0.08 and 0.4% of TE for 60 days. In the latter group, fasting blood glucose levels decreased (6.68 +/- 0.41 mmol/L) significantly (p<0.05) after a 60-day ingestion period compared with controls (8.75 +/- 0.54 mmol/L). Moreover, postprandial blood glucose levels were also significantly reduced (16.79 +/- 2.28 mmol/L; p<0.01) after ingesting TE for only 30 days compared with controls (28.49 +/- 0.59 mmol/L). On oral TE treatment for 60 days, postprandial increases in the blood glucose level after oral loading of sucrose (2 g/kg) at 30 (p<0.05) and 60 (p<0.01) min were significantly depressed compared with controls. Indexes for serum lipids; viz., total cholesterol (p<0.05) and triglyceride (p<0.01) levels significantly decreased after TE ingestion. Indexes for hepatic functions, such as glutamic-oxaloacetic transaminase (p<0.01), glutamic-pyruvic transaminase and gama-glutamyl transpeptide levels, were similarly suppressed. Organ weights of the heart, kidney, jejunum, liver and spleen increased in control KKAy mice due to hyperinsulinemia. Interestingly, the respective organ weights decreased (p<0.05, 0.01) and the jejunum length was reduced (p<0.05) significantly in the TE-treated groups. All in all, TE demonstrated an anti-hyperglycemic effect and may have potential use in the management of non-insulin-dependent diabetic mellitus.